Trials / Completed
CompletedNCT02006836
Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients
Glycemic Index & Glycemic Responses to Majia Pomelos
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Food intake has a great influence on blood glucose of patients with diabetes. This study was designed to determine the glycemic index (GI) of a particular pomelo named Majia pomelo and its effects on postprandial glucose (PPG) excursions in both healthy subjects and patients with type 2 diabetes (T2DM).
Detailed description
The purpose of this study was to evaluate the GI and effects on glucose excursion of Majia pomelo in both healthy and diabetic subjects. The results may help diabetic subjects and their health care providers in developing a diet that is both medically and culturally appropriate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pomelo | The sugar content of the pomelo was 5.86% of full weight, and we use 922g Majia pomelos which contained about 50g sugar equal to 50g glucose for GI measurement. |
| DIETARY_SUPPLEMENT | Glucose | We dissolved 50 g of glucose in 200 ml water. |
| OTHER | Blank | For the self-control period the diabetic patients underwent 3-day CSII treatment without change of insulin dose and we did not applied any intervention. |
| DRUG | Insulin | Patients who were included in the test of glycemic responses to postprandial pomelo consumption were hospitalized with the treatment of Continuous Subcutaneous Insulin Infusion(CSII), and the insulin for CSII was insulin aspart(NovoRapid). |
| DRUG | met or diet | In diabetic group, 20 diabetic patients were included for GI measurement , 18 of whom were on metformin treatment. Only 2 patients were on diet control due to the early stage of this disease. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-12-10
- Last updated
- 2014-06-26
- Results posted
- 2014-06-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02006836. Inclusion in this directory is not an endorsement.